StreetAlpha
Pacira BioSciences, Inc. · SEC Form 4

PCRX Insider Trading

From SEC Form 420 trades in 2 yearsUpdated Nov 19, 2026

Every open market buy and sale of Pacira BioSciences, Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $2.4M sold.

← PCRX stock page

Insiders are only selling
Bought, 12 months$00 buys · 0 insiders
Sold, 12 months$2.4M12 sales · 5 insiders
Net−$2.4Mbought minus sold
Planned sales100%of sold value, 10b5-1 plans

Buying and selling by month

open market, last 12 months
2025-12: sold $627KDec2026-01: sold $34KJan2026-02: sold $353KFeb2026-03: sold $85KMar2026-04: sold $628KAprMay2026-06: sold $372KJunJul2026-08: sold $71KAugSep2026-10: sold $218KOctNov
Bought (up)Sold (down)
AI Pro · insider alerts

Get an alert when PCRX insiders trade

We read every Form 4 the moment the SEC posts it and tell you when an PCRX officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.

Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.

Every PCRX insider trade

2 years · newest first
InsiderTypePriceHeld afterFiled
Oct 8, 2026Lauren RikerSenior Vice President, FinanceSale plan6,000$36.32$218K62,284Oct 9Form 4
Aug 17, 2026Jonathan SloninChief Medical OfficerSale plan3,040$23.23$71K216,384Aug 18Form 4
Jun 11, 2026Lauren RikerSenior Vice President, FinanceSale plan6,115$23.50$144K62,284Jun 12Form 4
Jun 4, 2026Kristen WilliamsChief Administrative OfficerSale plan10,259$22.27$228K167,062Jun 5Form 4
Apr 23, 2026Shawn CrossCFOSale plan12,941$25.16$326K105,341Apr 24Form 4
Apr 22, 2026Shawn CrossCFOSale plan12,059$25.09$303K105,341Apr 22Form 4
Mar 17, 2026Mark FroimsonDirectorSale500$21.81$11K20,136Mar 19Form 4
Mar 17, 2026Jonathan SloninChief Medical OfficerSale plan3,261$22.82$74K223,640Mar 19Form 4
Feb 2, 2026Kristen WilliamsChief Administrative OfficerSale plan13,137$20.53$270K131,303Feb 3Form 4
Feb 2, 2026Lauren RikerSenior Vice President, FinanceSale plan4,000$20.81$83K52,313Feb 3Form 4
Jan 5, 2026Lauren RikerSenior Vice President, FinanceSale plan1,416$24.24$34K59,064Jan 6Form 4
Dec 10, 2025Shawn CrossCFOSale plan25,000$25.07$627K56,250Dec 11Form 4
Nov 17, 2025Jonathan SloninChief Medical OfficerSale plan3,960$24.09$95K178,367Nov 19Form 4
Nov 10, 2025Shawn CrossCFOSale plan12,060$22.09$266K56,250Nov 13Form 4
Sep 4, 2025Abraham CeesayDirectorSale plan2,354$27.19$64K9,039Sep 8Form 4
🔒 5 more trades. Create a free account or sign in to see them all.

PCRX insider trading FAQ

Are PCRX insiders buying or selling?

Insiders are only selling over the last 12 months. 0 insiders bought $0 of PCRX on the open market in 0 trades, and 5 sold $2.4M in 12 trades, 100% of that under pre-arranged trading plans.

When did an PCRX insider last buy shares?

There has been no open market insider purchase of PCRX in the last two years.

When did an PCRX insider last sell shares?

Lauren Riker (Senior Vice President, Finance) sold 6,000 shares for $218K on Oct 8, 2026, under a pre-arranged trading plan.

What is a Form 4?

Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.

Why do insider sales matter less than buys?

Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.

From SEC Form 4 filings · Not investment advice